Showing results (2701-2710 of 2,892) with videos related to

Sort By:
Pageof 290
NPJ Digital Medicine|March 9, 2022
A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizationsRohan Khera, Bobak J Mortazavi, Veer Sangha, et al.
Physical Review Letters|April 2, 2016
Reduced Sensitivity to Charge Noise in Semiconductor Spin Qubits via Symmetric OperationM D Reed, B M Maune, R W Andrews, et al.
Nature Biomedical Engineering|March 30, 2019
Combinatorial interactions of genetic variants in human cardiomyopathyDekker C Deacon, Cassandra L Happe, Chao Chen, et al.
The Journal of Urology|October 7, 2018
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic TherapyJoseph M Jacob, Elizabeth K Ferry, Laurie M Gay, et al.
Circulation. Cardiovascular Quality and Outcomes|July 26, 2012
Variability in surgeons' perioperative practices may influence the incidence of low-output failure after coronary artery bypass grafting surgeryDonald S Likosky, Joshua B Goldberg, Anthony W DiScipio, et al.
Breast Cancer Research and Treatment|August 20, 2022
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility studyElaine M Walsh, Ayca Gucalp, Sujata Patil, et al.
BMJ Quality & Safety|September 6, 2011
How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborativeJeremiah R Brown, Peter A McCullough, Mark E Splaine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder CancerChiara Mercinelli, Marco Moschini, Antonio Cigliola, et al.
The American Journal of Surgical Pathology|February 19, 2024
Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to MyxofibrosarcomaErik A Williams, Isabella Vegas, Fardous F El-Senduny, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replicationAngela M Lam, Eisuke Murakami, Christine Espiritu, et al.
Pageof 290